Neuromuscular Blockade clinical trials at UCSF
1 research study open to eligible people
Comparison Of Rocuronium Reversal By Sugammadex To Succinylcholine For Electroconvulsive Therapy (ECT)
open to eligible people ages 18 years and up
The investigators propose to compare the recovery of neuromuscular blockade from rocuronium reversal by sugammadex to succinylcholine in ECT.
San Francisco, California